How Clinical Skincare Is Evolving: The 70-Year Medical Legacy Behind Modern Barrier Repair
That's where clinical skincare has started to gain real traction. Not the marketing kind, actual formulations that support inflammation control, barrier repair, and structural regeneration. You'll find them behind the counter at dermatology offices, or tucked into the routines of people who've had more than one procedure.
In fact, the U.S. market for post-laser recovery products is projected to more than double by 2030, reaching $293 million, driven largely by demand for evidence-based recovery solutions, according to Grand View Research.
Some of those formulations have been around longer than most of today's brands. One, in particular, began in a surgical setting, not a beauty lab. And while it wasn't built for store shelves, it's starting to reshape how post-procedure care is understood today. From Aesthetic Medicine to Clinical Skincare
The story starts in a private clinic on Harley Street, where a London-based plastic surgeon was treating patients through the final stages of recovery. The procedures went well and the outcomes proved to be strong. However, there was a gap in care once the sutures came out and the swelling faded, it appeared that skin wasn't bouncing back the way it should.
Most of what was available at the time focused on dryness or surface hydration. There wasn't much that addressed deeper issues like erythema, barrier stress, or lingering inflammation. That gap has since been backed by research, including a 2024 study showing that recovery-focused formulas can ease irritation, reduce water loss, and help the skin feel more stable after aesthetic treatments or procedures.
So, the surgeon started working on something himself, quietly, in-house, for patients who needed more than cosmetic relief. The results made their way from one clinic to another. Colleagues began asking for jars. For years, the medical-grade anti-aging formulas lived almost entirely within medical circles. No ads and no retail push, just word of mouth between professionals.
That model stayed in place until 2019, when the company moved under new ownership and opened the door to a broader release. The formulas didn't change, the accessibility did. The Rise of Clinical Skincare in a Post-Aesthetic World
Cosmetic procedures aren't rare anymore. Treatments like microneedling, peels, and fractional lasers are booked every day, and most patients don't need much convincing about the benefits. What they're focused on now is what happens after, the redness, the tightness, the recovery window that can either support results or slow them down.
That's where clinical skincare is becoming more relevant. When the skin's been through controlled trauma, it needs help repairing itself. Products that support barrier strength and dermal regeneration are showing up more often in dermatologists' aftercare plans, and in the routines of patients who've done this more than once. The goal is veering away from just hydration, and is more centered around function: calming inflammation, restoring structure, and making sure the results are sustained.
The change is becoming evident in the market. More people are choosing medical-grade skincare, especially when it comes to products that support recovery. There's a growing preference for science-backed results over cosmetic promises. This interest aligns with other breakthroughs in medical skin healing, even spray-on skin treatments are emerging in clinical discussions. A Legacy Brand Enters a New Era
In 2019, HERBMODA was revived under Custom Celebrity Beauty UK Limited, opening the door for its formulas once limited to medical settings to reach a broader audience. That timing aligned closely with renewed interest in evidence-based recovery products. This renewed direction culminated in HERBMODA's participation in a clinical skincare session in Cannes, where a professional forum reflected the brand's continued relevance among medical and ingredient-focused communities.
The event took place as a red carpet skincare masterclass held during the 2025 Cannes Film Festival. The event, attended by professionals across the skincare and wellness space, spotlighted brands aligned with science-backed innovation and ingredient transparency. For HERBMODA, it marked a visible moment in its global validation of clinical credibility.
The timing lined up with growing interest in post-procedure care, both from inside the field and from consumers who were paying closer attention to what actually works. What Defines a Science-Backed Skincare Formula?
Science-backed skincare is built with a specific purpose in mind. It's not just about how a product feels on the skin, it's about how it performs during repair, recovery, and inflammation control. That means using ingredients with documented effects on the skin barrier, inflammation response, and structural repair, especially after it's been compromised.
HERBMODA has developed a range of innovative products designed to support recovery and strengthen skin function. These formulas focus on helping the skin retain moisture, reduce visible irritation, and regain resilience after stress and disruption to the skin barrier.
Rather than relying on surface-level benefits, these formulations are designed with function and integrity in mind, prioritizing outcomes that dermatologists and ingredient-conscious users can trust. For skin that's been compromised, the right product can make the difference between prolonged recovery and visible repair. Generational Endorsement from the Medical Community
Dr. Thiago Freire, a London-based dermatologist with academic training across the U.S. and Europe, is one of several medical professionals who continue to speak highly of HERBMODA. With a background in anti-aging medicine and a deep interest in regenerative ingredients like exosomes, polynucleotides, and enzymes, his skincare philosophy centers on function and longevity.
His familiarity with HERBMODA goes back decades. " I remember my mother using it ," he noted in a recent interview. " It felt unique and carried a sense of ritual. " That early exposure stayed with him. Years later, when colleagues mentioned the brand in a product discussion, it caught his attention immediately.
To Dr. Freire, HERBMODA's ability to evolve while staying rooted in its professional foundation is what makes it relevant now. " When a brand that was once deeply trusted manages to reinvent itself decades later in a more modern form, it proves that its professional foundation has never wavered. " Founded in 1955 by a British plastic surgeon, the brand's original fusion of medicine and beauty aligns closely with his own approach to dermatology.
Even as skincare trends have shifted and new products continue to enter the market, some formulas haven't needed to change much. For Dr. Freire, that kind of longevity carries weight. With a background in both clinical dermatology and academic research, he's seen how patient outcomes often reinforce the value of a product long before it gains broader recognition.
In an industry that tends to move fast, this kind of long-term use inside medical practices speaks to something else: reliability. It's not always visible on shelves, but among dermatologists, it has remained part of the conversation for years. The Intersection of Trust and Science
Skincare is being approached with more intention. Consumers are asking better questions, paying attention to ingredients, and looking for products that can hold their own in clinical formulas that are recommended by dermatologists, particularly those designed for post-procedure recovery.
The growth in medical-grade skincare reflects that shift. According to a 2024 market report, the global medicated skincare market reached $36.7 billion and is projected to maintain an 8 percent annual growth rate through 2033. This momentum highlights demand for formulations that are backed by science. AI-driven diagnostic tools are starting to influence how skin conditions are assessed, blending technology with clinical decision-making. One app is already being used to help dermatologists identify issues through real-time image analysis.
HERBMODA's presence in the clinical space reflects that direction. Its formulations were originally developed for use inside medical settings, where function guided every decision. That focus has remained consistent. Looking Ahead: A Return to Purpose
Clinical skincare has found its place, not as a trend, but as part of everyday care for healing and recovery. More professionals and patients are turning to formulas that are grounded in science and designed with clear intention.
Brands rooted in medical practice are helping shape that direction. For dermatologists, editors, and ingredient-focused users, clinical heritage and formulation science go hand in hand. There's true value in products that have been used, studied, and refined in real treatment settings.
HERBMODA's path reflects this evolution, what began in surgical clinics has become part of a broader shift toward skincare that's made to work under real conditions. This kind of purpose-driven development is shaping how post-procedure care is understood, and where skin recovery is headed next.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Int'l Business Times
5 days ago
- Int'l Business Times
WHO Says Malnutrition Reaching 'Alarming Levels' In Gaza
Malnutrition rates are reaching "alarming levels" in the Gaza Strip, the World Health Organization warned Sunday, saying the "deliberate blocking" of aid was entirely preventable and had cost many lives. "Malnutrition is on a dangerous trajectory in the Gaza Strip, marked by a spike in deaths in July," the WHO said in a statement. Of the 74 recorded malnutrition-related deaths in 2025, 63 had occurred in July -- including 24 children under five, one child aged over five, and 38 adults, it added. "Most of these people were declared dead on arrival at health facilities or died shortly after, their bodies showing clear signs of severe wasting," the UN health agency said. "The crisis remains entirely preventable. Deliberate blocking and delay of large-scale food, health, and humanitarian aid has cost many lives." Israel on Sunday began a limited "tactical pause" in military operations to allow the UN and aid agencies to tackle a deepening hunger crisis. But the WHO called for sustained efforts to "flood" the Gaza Strip with diverse, nutritious food, and for the expedited delivery of therapeutic supplies for children and vulnerable groups, plus essential medicines and supplies. "This flow must remain consistent and unhindered to support recovery and prevent further deterioration", the Geneva-based agency said. On Wednesday, WHO chief Tedros Adhanom Ghebreyesus called the situation "mass starvation -- and it's man-made". Nearly one in five children under five in Gaza City is now acutely malnourished, the WHO said Sunday, citing its Nutrition Cluster partners. It said the percentage of children aged six to 59 months suffering from acute malnutrition had tripled in the city since June, making it the worst-hit area in the Palestinian territory. "These figures are likely an underestimation due to the severe access and security constraints preventing many families from reaching health facilities," the WHO said. The WHO said that in the first two weeks of July, more than 5,000 children under five had been admitted for outpatient treatment of malnutrition -- 18 percent of them with the most life-threatening form, severe acute malnutrition (SAM). The 6,500 children admitted for malnutrition treatment in June was the highest number since the war began in October 2023. A further 73 children with SAM and medical complications have been hospitalised in July, up from 39 in June. "This surge in cases is overwhelming the only four specialised malnutrition treatment centres," the WHO said. Furthermore, the organisation said the breakdown of water and sanitation services was "driving a dangerous cycle of illness and death". As for pregnant and breastfeeding women, Nutrition Cluster screening data showed that more than 40 percent were severely malnourished, the WHO said. "It is not only hunger that is killing people, but also the desperate search for food," the UN health agency said. "Families are being forced to risk their lives for a handful of food, often under dangerous and chaotic conditions," it added. The UN rights office says Israeli forces have killed more than 1,000 Palestinians trying to get food aid in Gaza since the Israel- and US-backed Gaza Humanitarian Foundation started operations in late May. Nearly three-quarters of them died near GHF sites.
Int'l Business Times
24-07-2025
- Int'l Business Times
How Clinical Skincare Is Evolving: The 70-Year Medical Legacy Behind Modern Barrier Repair
Lately, more dermatologists are talking about what happens with post-procedure skincare, not just the results. Whether it's laser, microneedling, or a simple resurfacing treatment, recovery has become part of the treatment plan. Patients are asking better questions. They want to know what helps the skin calm down, rebuild, and come back stronger. That's where clinical skincare has started to gain real traction. Not the marketing kind, actual formulations that support inflammation control, barrier repair, and structural regeneration. You'll find them behind the counter at dermatology offices, or tucked into the routines of people who've had more than one procedure. In fact, the U.S. market for post-laser recovery products is projected to more than double by 2030, reaching $293 million, driven largely by demand for evidence-based recovery solutions, according to Grand View Research. Some of those formulations have been around longer than most of today's brands. One, in particular, began in a surgical setting, not a beauty lab. And while it wasn't built for store shelves, it's starting to reshape how post-procedure care is understood today. From Aesthetic Medicine to Clinical Skincare The story starts in a private clinic on Harley Street, where a London-based plastic surgeon was treating patients through the final stages of recovery. The procedures went well and the outcomes proved to be strong. However, there was a gap in care once the sutures came out and the swelling faded, it appeared that skin wasn't bouncing back the way it should. Most of what was available at the time focused on dryness or surface hydration. There wasn't much that addressed deeper issues like erythema, barrier stress, or lingering inflammation. That gap has since been backed by research, including a 2024 study showing that recovery-focused formulas can ease irritation, reduce water loss, and help the skin feel more stable after aesthetic treatments or procedures. So, the surgeon started working on something himself, quietly, in-house, for patients who needed more than cosmetic relief. The results made their way from one clinic to another. Colleagues began asking for jars. For years, the medical-grade anti-aging formulas lived almost entirely within medical circles. No ads and no retail push, just word of mouth between professionals. That model stayed in place until 2019, when the company moved under new ownership and opened the door to a broader release. The formulas didn't change, the accessibility did. The Rise of Clinical Skincare in a Post-Aesthetic World Cosmetic procedures aren't rare anymore. Treatments like microneedling, peels, and fractional lasers are booked every day, and most patients don't need much convincing about the benefits. What they're focused on now is what happens after, the redness, the tightness, the recovery window that can either support results or slow them down. That's where clinical skincare is becoming more relevant. When the skin's been through controlled trauma, it needs help repairing itself. Products that support barrier strength and dermal regeneration are showing up more often in dermatologists' aftercare plans, and in the routines of patients who've done this more than once. The goal is veering away from just hydration, and is more centered around function: calming inflammation, restoring structure, and making sure the results are sustained. The change is becoming evident in the market. More people are choosing medical-grade skincare, especially when it comes to products that support recovery. There's a growing preference for science-backed results over cosmetic promises. This interest aligns with other breakthroughs in medical skin healing, even spray-on skin treatments are emerging in clinical discussions. A Legacy Brand Enters a New Era In 2019, HERBMODA was revived under Custom Celebrity Beauty UK Limited, opening the door for its formulas once limited to medical settings to reach a broader audience. That timing aligned closely with renewed interest in evidence-based recovery products. This renewed direction culminated in HERBMODA's participation in a clinical skincare session in Cannes, where a professional forum reflected the brand's continued relevance among medical and ingredient-focused communities. The event took place as a red carpet skincare masterclass held during the 2025 Cannes Film Festival. The event, attended by professionals across the skincare and wellness space, spotlighted brands aligned with science-backed innovation and ingredient transparency. For HERBMODA, it marked a visible moment in its global validation of clinical credibility. The timing lined up with growing interest in post-procedure care, both from inside the field and from consumers who were paying closer attention to what actually works. What Defines a Science-Backed Skincare Formula? Science-backed skincare is built with a specific purpose in mind. It's not just about how a product feels on the skin, it's about how it performs during repair, recovery, and inflammation control. That means using ingredients with documented effects on the skin barrier, inflammation response, and structural repair, especially after it's been compromised. HERBMODA has developed a range of innovative products designed to support recovery and strengthen skin function. These formulas focus on helping the skin retain moisture, reduce visible irritation, and regain resilience after stress and disruption to the skin barrier. Rather than relying on surface-level benefits, these formulations are designed with function and integrity in mind, prioritizing outcomes that dermatologists and ingredient-conscious users can trust. For skin that's been compromised, the right product can make the difference between prolonged recovery and visible repair. Generational Endorsement from the Medical Community Dr. Thiago Freire, a London-based dermatologist with academic training across the U.S. and Europe, is one of several medical professionals who continue to speak highly of HERBMODA. With a background in anti-aging medicine and a deep interest in regenerative ingredients like exosomes, polynucleotides, and enzymes, his skincare philosophy centers on function and longevity. His familiarity with HERBMODA goes back decades. " I remember my mother using it ," he noted in a recent interview. " It felt unique and carried a sense of ritual. " That early exposure stayed with him. Years later, when colleagues mentioned the brand in a product discussion, it caught his attention immediately. To Dr. Freire, HERBMODA's ability to evolve while staying rooted in its professional foundation is what makes it relevant now. " When a brand that was once deeply trusted manages to reinvent itself decades later in a more modern form, it proves that its professional foundation has never wavered. " Founded in 1955 by a British plastic surgeon, the brand's original fusion of medicine and beauty aligns closely with his own approach to dermatology. Even as skincare trends have shifted and new products continue to enter the market, some formulas haven't needed to change much. For Dr. Freire, that kind of longevity carries weight. With a background in both clinical dermatology and academic research, he's seen how patient outcomes often reinforce the value of a product long before it gains broader recognition. In an industry that tends to move fast, this kind of long-term use inside medical practices speaks to something else: reliability. It's not always visible on shelves, but among dermatologists, it has remained part of the conversation for years. The Intersection of Trust and Science Skincare is being approached with more intention. Consumers are asking better questions, paying attention to ingredients, and looking for products that can hold their own in clinical formulas that are recommended by dermatologists, particularly those designed for post-procedure recovery. The growth in medical-grade skincare reflects that shift. According to a 2024 market report, the global medicated skincare market reached $36.7 billion and is projected to maintain an 8 percent annual growth rate through 2033. This momentum highlights demand for formulations that are backed by science. AI-driven diagnostic tools are starting to influence how skin conditions are assessed, blending technology with clinical decision-making. One app is already being used to help dermatologists identify issues through real-time image analysis. HERBMODA's presence in the clinical space reflects that direction. Its formulations were originally developed for use inside medical settings, where function guided every decision. That focus has remained consistent. Looking Ahead: A Return to Purpose Clinical skincare has found its place, not as a trend, but as part of everyday care for healing and recovery. More professionals and patients are turning to formulas that are grounded in science and designed with clear intention. Brands rooted in medical practice are helping shape that direction. For dermatologists, editors, and ingredient-focused users, clinical heritage and formulation science go hand in hand. There's true value in products that have been used, studied, and refined in real treatment settings. HERBMODA's path reflects this evolution, what began in surgical clinics has become part of a broader shift toward skincare that's made to work under real conditions. This kind of purpose-driven development is shaping how post-procedure care is understood, and where skin recovery is headed next.
Int'l Business Times
18-07-2025
- Int'l Business Times
BIO INX: Bridging the Gap Between Regenerative Research and Real-World Impact
Decades of scientific discovery in tissue engineering and regenerative medicine have led to breakthroughs. However, the translation of these technologies into clinical therapies hasn't been as immediate as anticipated. BIO INX was founded to address this bottleneck. Its mission is to equip scientists, clinicians, and industry players with the reliable biomaterials they need to bring 3D bio-printing closer to everyday healthcare. BIO INX's co-founder and CEO, Jasper Van Hoorick, was driven by the belief that materials science could be the key to solving challenges in regenerative medicine. His background in polymer chemistry and a PhD focused on corneal regeneration opened his eyes to a repeating pattern in academic research. BIO INX's co-founder and CEO, Jasper Van Hoorick "Promising materials and prototypes would be developed, never further than academic publications, only to be shelved when the original researchers move on," Van Hoorick shares. Indeed, progress stalls without a reproducible and standardized pipeline for translating these materials into clinical-grade tools. Instead of waiting for innovation to make its way out of the lab, Van Hoorick decided to take action. Throughout the final stages of his PhD, Van Hoorick started planning BIO INX in earnest. He wrote grant proposals between thesis chapters, secured initial funding, and built a team that began maturing the company's first products while still operating within the academic environment. By the time the company officially spun out, it had already established partnerships and was positioned to take its materials beyond the proof-of-concept phase. Now, BIO INX is known for developing and offering high-performance, ready-to-use biomaterials for 3D bioprinting and biofabrication. These materials are crafted with reproducibility, scalability, and compatibility with multiple printing technologies in mind. The company has a diverse and adaptable product portfolio that supports various biomedical applications, from tissue regeneration to pharmaceutical screening. One of BIO INX's unique strengths is its multidisciplinary foundation. Its team, with over two decades of experience in polymer science, bioengineering, and printing technologies, combines academic expertise with an applied mindset. This enables the company to create materials tailored for specific biological purposes and ensure that those materials meet the technical demands of modern bioprinting platforms. Essentially, with solutions that span different material properties, resolution scales, and printing modalities, BIO INX helps remove the technical obstacles that typically delay or derail regenerative projects. A 3D printed scaffold to guide cell growth made out of DEGRES INX, a biodegradable polyester based resin The Belgium-based company is proud to share that it has been involved in several proof-of-concept projects that illustrate the clinical and scientific potential of its materials. One of them is the Astrocardia, a heart-on-a-chip experiment. The project has focused on modeling cardiovascular aging, a process that naturally takes decades but is dramatically accelerated in space. By bioprinting miniature cardiac tissues using a novel bioink, BIO INX has contributed to the development of human-derived aging models. These models may eventually support personalized therapies and more predictive drug screening approaches, both on Earth and in space. BIO INX has also participated in a project on ocular regeneration. Drawing from Van Hoorick's doctoral work on corneal tissue, the company has been tackling the shortage of viable donor tissue for corneal transplants. "Current treatments rely on corneas from human donors, but the supply is insufficient," Van Hoorick says. BIO INX has been working in collaboration with a clinical partner to develop bioinks that allow for the regeneration of corneal tissue without the need for invasive surgery. Because the eye is uniquely accessible and allows for direct visual monitoring, it presents a promising target for regenerative strategies. The potential to restore vision with personalized, cell-based therapies could represent a meaningful advancement for patients facing corneal blindness. A third area that has been in development is cartilage and bone regeneration. The InCart-3D initiative has explored how digital light processing (DLP) bioprinting can be combined with next-generation bioinks to rebuild complex skeletal tissues. Treating the cartilage is challenging because it lacks the natural ability to heal. By creating structurally accurate, cell-friendly constructs that can be integrated with underlying bone, BIO INX is contributing to new possibilities in orthopedic repair. The work builds on promising preclinical studies where regenerated cartilage enabled mobility recovery in animal models. Through this line of development, the company aims to support therapies for joint degradation, spinal conditions, and other structural issues that impact millions worldwide. The road to clinical application is complex and highly regulated. Efforts like those of BIO INX represent a step toward a more seamless integration between research and patient care. Through its commitment to standardization, investment in enabling technologies, and involvement in proof-of-concept projects, the company continues to support the field's gradual shift from theory to therapy.
